SR

Sunita Rajesh Tandulwadkar

Active Director Director DIN 07420728
DIN 07420728 First appointment May 2016 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since May 2016
Shareholding value •••• Premium profile

About Sunita Rajesh Tandulwadkar

Data last updated:

Sunita Rajesh Tandulwadkar is a Director at Solo Clinic Private Limited (since 2018), Designated Partner at Alreschaa Life Sciences Llp (since 2019) and Director at Solo Stemcells Private Limited (since 2016), and holds 2 more current directorships. The companies operate in Healthcare, Business Services and Home Appliances. The 4 current companies with reported revenue have a combined latest revenue of ₹6.82 Cr; the largest is Solo Clinic Private Limited at ₹5.34 Cr (FY 2024). Earlier, Sunita Rajesh Tandulwadkar was a Director at Alreschaa Ventures Private Limited (2020–2025).

DIN 07420728
Primary Designation Director
Industry Healthcare
First Appointment 05 May 2016
Oldest Company Age 10 yrs
Largest company Solo Clinic Private Limited · ₹5.34 Cr (FY 2024)
Combined revenue ₹6.82 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Solo Clinic Private Limited U74999PN2018PTC175994
Director12 Apr 20182018₹5.34 Cr (FY 2024)Active
Designated Partner02 Aug 20192019₹68.8 Lakh (FY 2024)Active
Solo Stemcells Private Limited U74999PN2016PTC164349
Director05 May 20162016₹66.6 Lakh (FY 2024)Active
Solo Research Foundation U74999PN2016NPL165291
Director30 Jun 20162016₹12.1 Lakh (FY 2024)Active
Alreschaa Llp AAN-7198
Designated Partner11 Dec 20182018Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alreschaa Ventures Private Limited U52609PN2020PTC191672
Director03 Jul 20202020Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Sunita Rajesh Tandulwadkar

Directorship timeline

Open interactive timeline →
Alreschaa Life Sciences Llp
Alreschaa Llp
Solo Research Foundation
Solo Stemcells Private Limited
Premium access

Shareholding and investment profile for Sunita Rajesh Tandulwadkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunita Rajesh Tandulwadkar

Sunita Rajesh Tandulwadkar currently holds 5 directorships: Solo Clinic Private Limited (Director, since 12 Apr 2018, revenue ₹5.34 Cr (FY 2024)); Alreschaa Life Sciences Llp (Designated Partner, since 02 Aug 2019, revenue ₹68.8 Lakh (FY 2024)); Solo Stemcells Private Limited (Director, since 05 May 2016, revenue ₹66.6 Lakh (FY 2024)); Solo Research Foundation (Director, since 30 Jun 2016, revenue ₹12.1 Lakh (FY 2024)); Alreschaa Llp (Designated Partner, since 11 Dec 2018).

Sunita Rajesh Tandulwadkar was first appointed on 05 May 2016 as Director at Solo Stemcells Private Limited. The most recent appointment on record is 03 Jul 2020 at Alreschaa Ventures Private Limited.

The 4 current companies of Sunita Rajesh Tandulwadkar that report revenue have a combined latest revenue of ₹6.82 Cr: Solo Clinic Private Limited ₹5.34 Cr (FY 2024); Alreschaa Life Sciences Llp ₹68.8 Lakh (FY 2024); Solo Stemcells Private Limited ₹66.6 Lakh (FY 2024); Solo Research Foundation ₹12.1 Lakh (FY 2024).

Sunita Rajesh Tandulwadkar held 1 earlier board appointment: Alreschaa Ventures Private Limited (Director, 03 Jul 2020 to 30 Mar 2025).

The current boards of Sunita Rajesh Tandulwadkar's companies include Rishi Rajesh Tandulwadkar (Solo Clinic Private Limited), Rajesh Chandrakant Tandulwadkar (Alreschaa Life Sciences Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available